Steven Cohen's position in Sarepta Therapeutics is currently worth $531 Thousand. That's 0.00% of their equity portfolio (859th largest holding). The first Sarepta Therapeutics trade was made in Q2 2014. Since then Steven Cohen bought shares 29 more times and sold shares on 37 occasions. The investor's estimated purchase price is $3.18 Million, resulting in a loss of 83%.